Figure S1. (a) Western blot of purified recombinant truncated His-hTAF9 1-140 and His-Fiber as detected by anti-His antibody. His-hTAF9 1-140 was verified.

Slides:

Advertisements

Similar presentations

Figure S1 b a c Supplement Figure 1. Basic functional characterization of B10G5 antibody. a. B10G5 neutralizing free sMICA in in vitro assay. Various concentration.

Advertisements

ER  HSP90 DMSO 200  M I3C30  M DIM200  M TRYPTOPHOL Supplemental Figure 1. DIM and Tryptophol fail to induce the downregulation of ER  seen with I3C.

Supplemental Figure 1. Remicade treatment did not affect body weight and muscle weight in mdx mice. Mdx mice were treated with Remicade (10 mg/ml) starting.

A U87 non-stem U87 stem-like U251 non-stem U251 stem-like MFI/FOV:TLR9 ** ,000 1,400 MFI/FOV:pSTAT ,200 ***

Molecular Therapy - Oncolytics

Saikosaponin-D Enhances Radiosensitivity of Hepatoma Cells under Hypoxic Conditions by Inhibiting Hypoxia-Inducible Factor-1α Cell Physiol Biochem 2014;33:37-51.

Volume 19, Issue 1, Pages (January 2011)

Arterioscler Thromb Vasc Biol

Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia by Hironori.

by Hong Hao, Huiling Qi, and Manohar Ratnam

Volume 85, Issue 2, Pages (January 2014)

A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia by Anja Ehrhardt, Hui.

Supplementary Figure S7

by Christopher J. Ott, Nadja Kopp, Liat Bird, Ronald M

Volume 8, Issue 5, Pages (May 2017)

Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator by Yan Jiao, John Wilkinson, Xiumin Di, Wei Wang,

Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation by Shiguo Zhu, Prasad V. Phatarpekar,

Upregulation of Inflammatory Cytokines and Oncogenic Signal Pathways Preceding Tumor Formation in a Murine Model of T-Cell Lymphoma in Skin Xuesong Wu,

Volume 85, Issue 2, Pages (January 2014)

Volume 8, Issue 6, Pages (December 2005)

Molecular Therapy - Nucleic Acids

Interaction of kindlin-3 and β2-integrins differentially regulates neutrophil recruitment and NET release in mice by Zhen Xu, Jiayi Cai, Juan Gao, Gilbert.

Volume 28, Issue 4, Pages (October 2015)

Volume 138, Issue 1, Pages e3 (January 2010)

Volume 138, Issue 5, Pages e2 (May 2010)

ALT-803 administration increases peripheral blood cell counts of lymphocyte subsets in cynomolgus monkeys. ALT-803 administration increases peripheral.

Inhibition of FGFR signaling and tumor growth in SNU-16 xenograft model by administration of E7090. Inhibition of FGFR signaling and tumor growth in SNU-16.

Volume 1, Issue 5, Pages (June 2002)

Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity Zhang-Xu Liu, Sugantha Govindarajan,

Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice Jörg.

The Circadian Clock Controls Immune Checkpoint Pathway in Sepsis

TWEAK/Fn14 Signals Mediate Burn Wound Repair

Volume 15, Issue 4, Pages (April 2016)

Antisense Targeting of cFLIP Sensitizes Activated T Cells to Undergo Apoptosis and Desensitizes Responses to Contact Dermatitis Dan V. Mourich, Jessica.

Volume 18, Issue 1, Pages (July 2010)

Volume 5, Issue 3, Pages (September 2015)

Supplementary Figure 1. Structure of amlexanox

Volume 8, Issue 1, Pages (January 2017)

Volume 20, Issue 2, Pages (February 2013)

miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK

Anke Sparmann, Dafna Bar-Sagi Cancer Cell

FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2 Walbert J. Bakker, Isaac S. Harris, Tak.

Molecular Therapy - Nucleic Acids

Interleukin-18 and the Costimulatory Molecule B7-1 Have a Synergistic Anti-Tumor Effect on Murine Melanoma; Implication of Combined Immunotherapy for.

Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy

Volume 13, Issue 3, Pages (March 2006)

Volume 14, Issue 2, Pages (February 2001)

Mark A. Rovedo, Nancy L. Krett, Steven T. Rosen

Overexpression of HGF decreases MET protein levels.

ULK1 Phosphorylates and Regulates Mineralocorticoid Receptor

Targeting Nonclassical Oncogenes for Therapy in T-ALL

Volume 18, Issue 3, Pages (March 2010)

Rapamycin inhibits KGF-induced mortality, proliferation, cytokine expression, and susceptibility to IAV infection, in vivo. Rapamycin inhibits KGF-induced.

Duy Pham, PhD, Sarita Sehra, PhD, Xin Sun, PhD, Mark H. Kaplan, PhD

Volume 25, Issue 11, Pages e6 (December 2018)

Effects of Z-FA-FMK on SMN protein expression in type II SMA patient fibroblast cells (GM22592). Effects of Z-FA-FMK on SMN protein expression in type.

DNM inhibition affects ITGB1 activity and Rab11 cell distribution in human MKs. (A-B) Quantification of active ITGB1 at the surface of MKs. Representative.

Diclofenac treatment reduces L-selectin on peripheral blood and infiltrated leukocytes but does not alter accumulation in the injured spinal cord. Diclofenac.

CO-1686 does not inhibit WT EGFR signaling in vivo and is active in EGFR-mutant transgenic mouse lung cancer models. CO-1686 does not inhibit WT EGFR signaling.

Silencing Socs1 in the LLC line confers increased response to IFNγ in vitro and in vivo. Silencing Socs1 in the LLC line confers increased response to.

Volume 19, Issue 1, Pages (January 2011)

Volume 24, Issue 10, Pages (October 2016)

Paracrine Apoptotic Effect of p53 Mediated by Tumor Suppressor Par-4

Antitumor activity of HER2-lytic hybrid peptide in tumor xenograft model in vivo. Antitumor activity of HER2-lytic hybrid peptide in tumor xenograft model.

Overexpression of L1 in CRC cells induces NF-κB activation and suppression of p65 expression blocks the capacity to confer liver metastasis. Overexpression.

Pirh2 represses p73-dependent transactivation.

Signal Transducer and Activator of Transcription 3 as Molecular Therapy for Non–Small- Cell Lung Cancer Cheng-Yi Wang, MD, Ting-Ting Chao, PhD, Wei-Tien.

Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression Jun-Li Luo, Shin.

Treatment with a Ron inhibitor significantly reduces metastatic outgrowth. Treatment with a Ron inhibitor significantly reduces metastatic outgrowth. A,

GCS-100 selectively kills KRAS-addicted lung tumors.

Presentation transcript:

Figure S1. (a) Western blot of purified recombinant truncated His-hTAF and His-Fiber as detected by anti-His antibody. His-hTAF was verified by anti-TAF9 antibody. (b) ELISA showed direct binding between biotinylated p53 peptide (with putative TAF9 binding motif) and purified recombinant His-hTAF , but not the recombinant His-Fiber protein. (c) Gli dependent transcription activity was significantly inhibited by knocking down TAF9 expression with TAF9 shRNA in NSCLC cell line A549. His-Fiber His-TAF9 WB: anti-His anti-TAF9 His-TAF9 His-Fiber a Ctrl shRNA TAF9 shRNA Gli1 + TAF9Gli2 + TAF9 Gli BS-luc activity (%) biotin-p53 peptide c b

Figure S2. Effect of FN1-8 on other transcription factors. (a) CREB and HIF binding sites-luciferase reporter activities in stable cell lines 293 and NIH3T3 (Panomics) were not affected by FN1-8 (10 and 20 µM, 1 day). (b) The SOCS3 promoter (with STAT3 binding sites, (He, et al. BBRC 2003)) activity in A549 cells was not affected by by FN1-8 (20 µM, 1 day). All the measured luciferase activities were normalized to pRL ‑ TK vector (Promega) activity. Results are means + S.D. DMSO10µM FN1-820µM FN1-8 a b

b Live cells (%) DMSO10 µM FN1-830 µM FN1-8 Normal muscle cellsNormal renal cells c Figure S3. Effect of FN1-8 on survival in several types of human normal cells. (a) Normal lung cells and (b) Normal muscle and renal cells were treated with different doses of FN1-8 for 4 days and then analyzed by flow cytometry. (c) Normal skin fibroblast were treated with different doses of FN1-8 and analyzed by MTS assay (time course). All results are mean values ± S.D. (error bars). DMSO 10 µM FN µM FN1-8 Normal skin fibroblast Days Live cells (%) Normal lung cells FN1-8 a

DMSO FN1-8 Kidney cortexKidney medulla Lung Spleen Liver Small intestineColon Ear c Figure S4. Pharmacokinetic (PK) and toxicity studies of FN1-8 in mice. (a) PK study of FN1-8 in mice (n=3) by i.p. injection (30 mg/kg). Results are means±SD. (b), (c) and (d) are toxicity analyses of FN1-8 in mice harboring H460 tumors of the efficacy study described in Figure 6. Body weights of mice were monitored during the period of drug administration (b). Hematoxylin and eosin (H&E) staining of organs (c). Leukocytes (WBC: white blood cell, NE: neutrophil, LY: lymphocyte, MO: monocyte, EO: eosinophil, BA: basophil) from animals were collected and counted through a blood cell counter (d). Normal ranges (x10 3 counts/ul) for the leukocyte population are: WBC: ; NE: ; LY: ; MO: 0-0.4; EO: 0-0.2; BA: Leukocyte population Counts (10 3 /μl) FN1-8 Vehicle d a FN1-8 Vehicle b i.p. injection Concentration (ng/ml) Time (hrs)

Table S2. Primer sequences for semi-quantitative RT-PCR GenePrimer SequencesSize (bp) Gli1F: 5’-TACTCACGCCTCGAAAACCT-3’ R: 5’-GTCTGCTTTCCTCCCTGATG-3’ 340 Gli2F: 5’-CACCAACCAGAACAAGCAGA-3’ R: 5’-ACCTCAGCCTCCTGCTTACA-3’ 195 ShhF: 5’-CAGTGGCCAGGAGTGAAACT-3’ R: 5’-CCAGGAAAGTGAGGAAGTCG-3’ 380 Ptch1F: 5’-CGCCTATGCCTGTCTAACCATGC-3’ R: 5’-TAAATCCATGCTGAGAATTGCA-3’ 448 GAPDHF: 5'-ATGGGGAAGGTGAAGGTCGG-3' R: 5'-GACGGTGCCATGGAATTTGC-3' 180 Table S1. Peptide sequences for ELISA Protein MotifPeptide Sequences Gli1-TAF9bd(NH2)-LDSLDLDNTQLDFVAILDEPQG-(COOH) Gli2-TAF9bd(NH2)-VDSQLLEAPQIDFDAIMDDGDH-(COOH) Mutant Gli2-TAF9bd(NH2)-VDSQLLEAPQIDADAIADDGDH-(COOH) p53-TAF9bd(NH2)-DPSVEPPLSQETFSDLWKLLPE-(COOH)